1
Participants
Start Date
December 19, 2018
Primary Completion Date
May 23, 2019
Study Completion Date
May 23, 2019
Pentamidine
Pentamidine will be administered as an IV infusion on treatment day 1-3 of a 21-day cycle 3 cycles using 2, 3, and 4 mg/kg dose escalation schedules. Non-investigational agents will be administered as follows: Ifosfamide 5000 mg/m2, Carboplatin 5 area under curve (AUC), and Etoposide 100 mg/mg2.
University of Kentucky Markey Cancer Center, Lexington
Reinhold Munker
OTHER